000			02029 a2200541 4500
005			20250516073256.0
264		0	_c20121009
008			201210s 0 0 eng d
022			_a1476-5551
024	7		_a10.1038/leu.2012.7 _2doi
040			_aNLM _beng _cNLM
100	1		_aMakishima, H
245	0	0	_aCBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors. _h[electronic resource]
260			_bLeukemia _cJul 2012
300			_a1547-54 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aBlotting, Western
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aFlow Cytometry
650	0	4	_aGranulocyte-Macrophage Colony-Stimulating Factor _xmetabolism
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aLeukemia, Myeloid, Acute _xdrug therapy
650	0	4	_aMutation _xgenetics
650	0	4	_aPhosphorylation _xdrug effects
650	0	4	_aPrognosis
650	0	4	_aProtein Binding
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-cbl _xgenetics
650	0	4	_aProto-Oncogene Proteins c-kit _xgenetics
650	0	4	_aRNA, Messenger _xgenetics
650	0	4	_aReal-Time Polymerase Chain Reaction
650	0	4	_aReceptor Protein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReverse Transcriptase Polymerase Chain Reaction
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTumor Cells, Cultured
650	0	4	_asrc-Family Kinases _xantagonists & inhibitors
700	1		_aSugimoto, Y
700	1		_aSzpurka, H
700	1		_aClemente, M J
700	1		_aNg, K P
700	1		_aMuramatsu, H
700	1		_aO'Keefe, C
700	1		_aSaunthararajah, Y
700	1		_aMaciejewski, J P
773	0		_tLeukemia _gvol. 26 _gno. 7 _gp. 1547-54
856	4	0	_uhttps://doi.org/10.1038/leu.2012.7 _zAvailable from publisher's website
999			_c21462071 _d21462071